Drug Profile
ISIS 104838
Alternative Names: TNF-alpha antisense inhibitor - Isis; TNF-alpha inhibitor - Isis; Tumour necrosis factor-alpha inhibitor - IsisLatest Information Update: 24 Oct 2021
Price :
$50
*
At a glance
- Originator Isis Pharmaceuticals
- Class Anti-inflammatories; Antisense oligonucleotides
- Mechanism of Action Immunosuppressants; Tumour necrosis factor inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Crohn's disease; Inflammation; Psoriasis; Rheumatoid arthritis
Most Recent Events
- 03 Mar 2005 Discontinued - Phase-I for Crohn's disease in USA (IV)
- 03 Mar 2005 Discontinued - Phase-I for Crohn's disease in USA (PO)
- 03 Mar 2005 Discontinued - Phase-I for Crohn's disease in USA (SC)